Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Brachytherapy|December 22, 2009
The impact of perineural invasion on biochemical outcome after permanent prostate iodine-125 brachytherapyAlfonso Gómez-Iturriaga Piña, Juanita Mary Crook, Paul Kwan, et al.
Journal of Pain and Symptom Management|July 26, 2021
Symptoms and Suffering at End of Life for Children With Complex Chronic ConditionsKatherine L Marcus, Pei-Chi Kao, Clement Ma, et al.
Cancer Medicine|May 1, 2020
Sponsorship of oncology clinical trials in the United States according to age of eligibilityDylan V Neel, David S Shulman, Clement Ma, et al.
JMIR Human Factors|July 19, 2023
Understanding the Role of Patient Portals in Fostering Interprofessional Collaboration Within Mental Health Care Settings: Mixed Methods StudyKeri Durocher, Hwayeon Danielle Shin, Brian Lo, et al.
Plos One|January 8, 2025
Relationship between mental health and substance abuse on COVID-19 vaccine hesitancy in youth: A mixed methods longitudinal cohort studyLouis Everest, Joanna Henderson, Clement Ma, et al.
Pediatric Blood & Cancer|December 1, 2020
Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysisLenka A Ilcisin, Clement Ma, Katherine A Janeway, et al.
Pediatric Blood & Cancer|September 14, 2021
Thinking ahead: Parents' worries about late effects of childhood cancer treatmentKatie A Greenzang, Colleen A Kelly, Hasan Al-Sayegh, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2010
A phase III randomized trial of the timing of meloxicam with iodine-125 prostate brachytherapyJuanita Crook, Nikhilesh Patil, Kris Wallace, et al.
Leukemia & Lymphoma|December 6, 2011
Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factorsDavid Telio, Kim Fernandes, Clement Ma, et al.
JCO Precision Oncology|December 23, 2024
Targeted-Agent Continual Reassessment Method: A Novel Bayesian Enrichment Design for Phase I Trials of Molecularly Targeted TherapiesClement Ma, David S Shulman, Hasan Al-Sayegh, et al.
Pageof 13